DOW CHEMICAL CO /DE/

txn_type = TENDER_OFFERSC TO-I/A 1 d35918dsctoia.htm SC TO-I/ AMENDMENT NO. 3 SC TO-I/ Amendment No. 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO/A (Amendment No. 3) (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 THE DOW CHEMICAL COMPANY (Name of Subject Company (Issuer) and Filing Person (Offeror)) Common Stock (Title of Class of Securities) 260543103 (CUSIP Number of Class of Securities) Charles J. Kalil General Counsel and Executive Vice President The Dow Chemi...

accepted = 34108738...supplemented by adding the following thereto: Pursuant to the exchange offer, which expired on October 5, 2015 at 8:00a.m., New York City time, and based on the final count by the exchange agent, Dow accepted 34,108,738 shares of Dow common stock for exchange in the Exchange Offer. A total of 161,106,659 shares of Dow common stock were validly tendered in the exchange offer, including 341,686 shares tendered by shareholders who qualified for and elected odd-lot treatment. Shareholders who elected odd-...

expired_on = 2015-10-05...common stock”), that are validly tendered and not properly withdrawn prior to the expiration of the Exchange Offer (as defined below). Immediately following consummation of the Exchange Offer, which expired at 8:00 a.m. on October 5, 2015, Blue Cube Acquisition Corp., a Delaware corporation (“Merger Sub”), which is a wholly-owned subsidiary of Olin Corporation (“Olin”), merged (the “Merger”) with and into Blue Cube Spinco Inc. (“Splitco”), whereby the separate corporate existence of Merger Sub ceased and Splitco...

tendered = 161106659...October 5, 2015 at 8:00a.m., New York City time, and based on the final count by the exchange agent, Dow accepted 34,108,738 shares of Dow common stock for exchange in the Exchange Offer. A total of 161,106,659 shares of Dow common stock were validly tendered in the exchange offer, including 341,686 shares tendered by shareholders who qualified for and elected odd-lot treatment. Shareholders who elected odd-lot treatment were not subject to proration, and their shares were fully accepted in the offer. All remaining tendered shares of...